Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04838210 · ClinicalTrials.gov registry record · NA
Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care
A NA study of Pregnancy Related and Perinatal Depression, sponsored by Washington University School of Medicine.
- Active
- Registry status
- NA
- Development phase
- 416
- Enrollment target
- 4
- Study locations
NCT04838210: Active NA study of Pregnancy Related and Perinatal Depression, sponsored by Washington University School of Medicine.
NCT04838210 is a NA study of Pregnancy Related and Perinatal Depression that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 416 participants, below the 1,959-participant average among 99 other Pregnancy Related trials with a reported enrollment target (79% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04838210, a NA study of Pregnancy Related and Perinatal Depression, is active but no longer recruiting, sponsored by Washington University School of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 416 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study will provide high-quality, representative data on the capacity of Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care (EleVATE GC) to reduce perinatal depression, preterm birth, and low birthweight in African-American women. If findings from this study indicate that EleVATE GC is feasible and effective, this model could be implemented nationwide to help achieve mental and obstetric health parity for low-income women of color in the United States.
Primary Outcome
Major Depression (Edinburgh Postnatal Depression Scale Score, range: 0-30, higher scores are a worse outcome)
Conditions Studied
Interventions
- BEHAVIORAL EleVATE Group Care
- BEHAVIORAL Individual Prenatal Care
Study Locations (4)
Missouri
- University of Missouri-Kansas City/Truman Health Centers-Kansas City - Kansas City
- Affinia Healthcare - St Louis
- Family Care Health Centers - St Louis
- CareSTL Health - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 416 participants |
| Start Date | 2021-05-21 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT04838210 still lists
NCT04838210 is an interventional study that assigns participants to a tested intervention. The registered 416 participants enrollment target is mid-sized for trials with a published cap, below the 1,959-participant average among 99 other Pregnancy Related trials with a reported enrollment target (79% lower).
The record links to 2 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 2 interventions - of which EleVATE Group Care is the first listed.
NCT04838210 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04838210 about?
NCT04838210 is a clinical study titled "Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care". This study will provide high-quality, representative data on the capacity of Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care (EleVATE GC) to reduce perinatal depression, preterm birth, and low birthweight in African-American women. If findings from this study ...
What is the current status of trial NCT04838210?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 416 participants. The study started on 2021-05-21. Estimated completion is 2026-06-30.
What conditions does trial NCT04838210 study?
This clinical trial studies the following conditions: Pregnancy Related, Perinatal Depression.
What interventions are being tested in trial NCT04838210?
The interventions under investigation include: EleVATE Group Care (BEHAVIORAL), Individual Prenatal Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT04838210?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04838210 being conducted?
This trial has 4 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04838210's enrollment target sits among peer trials
416 33rd of 99 higher than 67 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Accountability for Care Through Undoing Racism & Equity for Moms
RECRUITING · NA
-
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
MAMA Tot - Healthy Weight Parallel Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT05520099 · 416 participants
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
- NCT06075745 · 416 participants · Phase 2
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI